PLOD3 suppression exerts an anti-tumor effect on human lung cancer cells by modulating the PKC-delta signaling

Jeong-Hwa Baek1,2, Hong Shik Yun1, Gyoo Taik Kwon1

  • 1Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, 01812, Korea.

Cell Death & Disease
|February 17, 2019
PubMed

Insights

Targeting procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3) with siRNA inhibits lung cancer growth. PLOD3 knockdown overcomes chemoresistance and radioresistance by inducing apoptosis, suggesting PLOD3 as a therapeutic target and biomarker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Lung cancer treatments require novel targets due to unsatisfactory outcomes.
  • Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3) is implicated in fibrosis and tissue remodeling.
  • PLOD3 is identified as a radioresistance-related protein in lung cancer cells, but its mechanism remains unclear.

Purpose of the Study:

  • To investigate the role of PLOD3 in lung cancer radioresistance and chemoresistance.
  • To evaluate the therapeutic potential of targeting PLOD3 using short interfering (si)RNAs.
  • To elucidate the molecular mechanisms by which PLOD3 influences cancer cell apoptosis and treatment response.

Main Methods:

  • Design and application of human PLOD3-specific siRNAs.
  • In vitro and in vivo experiments to assess tumor growth inhibition.
  • Analysis of apoptosis pathways, including caspase activation and the unfolded-protein response (UPR).
  • Correlation analysis between PLOD3 expression and patient prognosis.

Main Results:

  • PLOD3 knockdown sensitized lung cancer cells to chemotherapy and radiotherapy by inducing caspase-3-dependent apoptosis.
  • PLOD3 interacts with PKCδ, activating caspase-2,4-dependent apoptosis via ER-stress-induced IRE1α activation and UPR.
  • PLOD3 siRNA significantly enhanced radiation-induced tumor growth inhibition in a mouse xenograft model without observable side effects.
  • High PLOD3 expression in lung cancer patients correlated with poorer prognosis following radiotherapy.

Conclusions:

  • PLOD3 plays a critical role in promoting lung cancer radioresistance and chemoresistance.
  • PLOD3 siRNA effectively suppresses tumor growth by inducing apoptosis, presenting a potential therapeutic strategy.
  • PLOD3 serves as a promising biomarker for predicting treatment response and patient prognosis in lung cancer.
  • Targeting PLOD3 offers a potential approach to enhance the efficacy of radiotherapy and chemotherapy in lung cancer patients.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.3K
The Delta-to-Delta Circuit01:17

The Delta-to-Delta Circuit

In a delta-delta configuration, the source and the load are connected in a delta manner, forming a closed loop that divides the network into three distinct phases. This configuration makes the phase voltages identical to line voltages. Assuming the sources are in positive sequence, the phase voltages can be expressed directly without having a neutral wire.
1.1K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.4K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.6K